Global stock markets are higher this morning after a second COVID-19 vaccine showed promising results, even as new cases continue to surge around the globe.
It's Main Street's Turn
to Get Paid | | | Wall Street has gone completely off the rails…
Their multi-billion dollar algorithms are on the loose… controlling the majority of the stock market and triggering massive STORM stock explosions.
I'm talking about 458% on Regeneron Pharmaceuticals Inc (Nasdaq: REGN) in 77 days… 743% on Intuit Inc. (Nasdaq: INTU) in 35 days… and even 606% on Seagate Technology PLC (Nasdaq: STX) in 101 days.
But now it's Main Street's turn to get paid…
I'm ready to reveal my top secret discovery, and how it could earn you 30 times the S&P every single year on average. | | | | | | | Roger Scott | 20+ years of trading experience managed over $900 million teaching thousands daily. | | | | | | Global Shares Soar on Upbeat COVID-19
Vaccine Data | | | | |
Global stock markets are higher this morning after a second COVID-19 vaccine showed promising results, even as new cases continue to surge around the globe.
Moderna Inc (Nasdaq: MRNA), an American biotechnology company that focuses on drug development, said its coronavirus vaccine seems to be 94.5% effective. But like Pfizer Inc. (NYSE: PFE) stated last week, the drug is still in its preliminary stages.
That means we have a long way to go, folks…
In today's video, I'll also explain which major index is leading the stock market… the biggest economic data driving stocks right now… which sector is lagging behind the most… and one weak stock showing a descending triangle pattern. | | | | |  |
| November 14, 2020 | The stock market is like a shooting target… and here at WealthPress we're determined to hit a bullseye on every trade we place. And while we're no lousy shots, there are certain tricks we've had to learn to make our aim more accurate… bringing out the big guns while minimizing any shockwaves headed toward our trading accounts. That's why market expert Adam Sarhan is telling viewers about his new approach to trading the stock market.
Continue Reading | |  |
| November 13, 2020 | The upsurge in COVID-19 infections in many parts of the world has put a damper on investor confidence that Pfizer Inc's (NYSE: PFE) vaccine could return things back to normal, and that pro-business policies (like fresh economic aid talks) will continue. But that's not the case, folks…
Continue Reading | | | | |
0 Response to "Global Shares Soar on Upbeat COVID-19 Vaccine Data"
Post a Comment